AFAM Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-90,417
Closed -$6.57M 159
2015
Q1
$6.57M Sell
90,417
-294
-0.3% -$20.9K 0.85% 44
2014
Q4
$6.26M Buy
90,711
+384
+0.4% +$25.9K 0.8% 46
2014
Q3
$5.86M Buy
90,327
+586
+0.7% +$37.1K 0.74% 57
2014
Q2
$5.58M Buy
89,741
+1,759
+2% +$105K 0.7% 65
2014
Q1
$5.18M Buy
+87,982
New +$4.91M 0.7% 68

Other funds holding LLY

AFAM Capital's LLY Position: Q2 2015 in Review

AFAM Capital sold out of Eli Lilly (LLY) in Q2 2015, closing a stake of 90,417 shares — an estimated $6.57M sold.

AFAM Capital first reported a position in LLY in Q1 2014 and held it in 5 quarters. The position peaked at $6.57M in Q1 2015. 1,138 funds tracked by Wall St. Rank hold LLY as of Q2 2015.

  • AFAM Capital reported no remaining Eli Lilly position as of Q2 2015 after selling out during the quarter.
  • AFAM Capital sold 90,417 Eli Lilly shares in Q2 2015, an estimated $6.57M.
  • AFAM Capital first reported a position in Eli Lilly in Q1 2014 and held it in 5 quarters.
  • AFAM Capital's Eli Lilly position peaked at $6.57M in Q1 2015.
  • 1,138 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2015.

Based on AFAM Capital's 13F filing for Q2 2015, filed 10 Aug 2015.